These data are consistent with the hypothesis that reconstitution of the pool of innate CD8(+) T cells and its partial functional restoration together with those of NK cells and iNKT cells effectively contribute to disease control of CML during TKI therapy. Here, CD8A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.